AVCT: Avacta Group Plc - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Avacta Group Plc

LON:AVCT

SummaryFactSheetFinancial
Price
£0.82
Loss Chance
58.3%
0.25JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Biotechnology
15 / 16
Health Care
66 / 67
United Kingdom
?
856 / 884
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Palatin Technologies
LON:0KF3
2.08
$15.24
100.00%
4basebio PLC
LON:4BB
1.85
£4.45
100.00%
Aptamer Group PLC
LON:APTA
1.46
£0.01
100.00%
Arecor Therapeutics plc
LON:AREC
2.46
£0.66
100.00%
BSF Enterprise Plc
LON:BSFA
2.12
£0.02
100.00%
Jitta Factors
Growth Opportunity (22)
Recent Business Performance (25)
Financial Strength (31)
Return to Shareholders (0)
Competitive Advantage (18)
Jitta Signs
Revenue and EarningEarning loss detected in 2024
Operating MarginDeclined
Recent Business PerformanceEarning decline 186.05% in the last quarter (yoy)
CapExVery High
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
0.25
100.00%
1.95
101.42%
3.14
125.88%
Biotechnology
2.08
100.00%
1.85
100.00%
1.46
100.00%
COMPANY DESCRIPTION
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.
avacta.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.